Aternalis Capital LLC 13F Portfolio & Position Changes
Aternalis Capital LLC
CIK: 0001638901
Long-term holder
Total reported value
—
Reporting period: 2016-12-31 · Number of holdings: 1
ATERNALIS CAPITAL LLC disclosed 1 holdings in its latest 13F filing for the period ending 2016-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
Unchanged 00000000
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Not enough priced holdings yet to compute performance
Position changes disclosed by Aternalis Capital LLC for the quarter ending 2016-12-31, including ticker, issuer, weight change, shares change, and action
What is Aternalis Capital LLC and what type of investor is it?
Aternalis Capital LLC is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2016-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Aternalis Capital LLC's largest equity positions?
Based on the latest 13F filing, Aternalis Capital LLC's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Aternalis Capital LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Aternalis Capital LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Aternalis Capital LLC focus on?
Sector breakdown data is not yet available for Aternalis Capital LLC. Check back after the next 13F processing cycle.